Association of Aldosterone Concentration and Mineralocorticoid Receptor Genotype with Potassium Response to Spironolactone in Patients with Heart Failure-Reference-Cited by-同舟云学术

Association of Aldosterone Concentration and Mineralocorticoid Receptor Genotype with Potassium Response to Spironolactone in Patients with Heart Failure

Published:2010-01 Issue:1 Volume:30 Page:1-9
ISSN:0277-0008
Container-title:Pharmacotherapy
language:en
Short-container-title:Pharmacotherapy

Author:

Cavallari Larisa H,Groo Vicki L,Viana Marlos A. G,Dai Yang,Patel Shitalben R,Stamos Thomas D

Publisher

Wiley

Subject

Pharmacology (medical)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1592/phco.30.1.1/fullpdf

Reference28 articles.

1. Effect of mineralocorticoid activity on transtubular potassium gradient, urinary [K]/[Na] ratio, and fractional excretion of potassium

2. Collagen Metabolism in Cultured Adult Rat Cardiac Fibroblasts: Response to Angiotensin II and Aldosterone

3. The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure

4. 2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults

5. Effectiveness of Spironolactone Added to an Angiotensin-Converting Enzyme Inhibitor and a Loop Diuretic for Severe Chronic Congestive Heart Failure (The Randomized Aldactone Evaluation Study [RALES])**See Appendix for full list of RALES investigators.

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Increased Spironolactone Dosing in Acute Heart Failure Alters Potassium Homeostasis but Does not Enhance Decongestion;Journal of Cardiac Failure;2024-07

2. Renal effects and safety between Asian and non‐Asian chronic kidney disease and type 2 diabetes treated with nonsteroidal mineralocorticoid antagonists;Journal of Diabetes;2024-05-16

3. Cardiorenal benefits of finerenone in different races and kidney function in patients with chronic kidney disease;Cardiorenal Medicine;2024-03-27

4. NR3C2 genotype is associated with response to spironolactone in diastolic heart failure patients from the Aldo‐DHF trial;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2021-10-12

5. Hyperkalemia and management of renin-angiotensin-aldosterone system inhibitors in chronic heart failure with reduced ejection fraction: A systematic review;Revista Portuguesa de Cardiologia;2020-09